Healthcare Services

Gastroparesis Industry Expansion Forecast Showing Market Size of $9.29 Billion by 2030 at 5.5% CAGR

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Is The Market Size Of The Gastroparesis Market Expected To Change Between 2026 And 2030?

The gastroparesis market has demonstrated strong expansion over recent years. Forecasts indicate its size will increase from $7.15 billion in 2025 to $7.52 billion in 2026, progressing at a compound annual growth rate (CAGR) of 5.1%. The historic growth in this market is attributable to various factors including diabetes-related gastric disorders, the utilization of antiemetic medications, hospital-based GI care services, dietary management approaches, and the increased availability of diagnostic imaging.

The gastroparesis market size is anticipated to undergo significant expansion over the next few years. It is projected to reach $9.29 billion by 2030, progressing at a compound annual growth rate (CAGR) of 5.5%. This growth during the forecast period is attributable to advancements in implantable stimulation devices, the development of outpatient treatment models, an increasing diabetic population, the demand for symptom-specific therapies, and enhanced clinical awareness. Notable trends expected in the forecast period feature a greater application of prokinetic medications, the increasing embrace of gastric electrical stimulation devices, a heightened emphasis on dietary and lifestyle management, the proliferation of minimally invasive surgical alternatives, and more accurate diagnosis of diabetic gastroparesis.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12189&type=smp

Which Major Factors Are Driving The Expansion Of The Gastroparesis Market?

The growing occurrence of diabetes is anticipated to drive the gastroparesis market forward. Diabetes is a chronic health condition identified by elevated blood glucose levels due to the body’s inability to produce enough insulin or effectively utilize the insulin it produces. The widespread nature of diabetes considerably raises the chances of developing gastroparesis, as it plays a significant role in increasing the population vulnerable to this condition. For example, in April 2025, the International Diabetes Federation, a Belgium-based advocacy organization, stated that nearly one in nine adults (589 million) globally are currently living with diabetes. Of these, an estimated 252 million are unaware of their condition, putting them at higher risk of serious complications and early death. Thus, the rapid increase in diabetes prevalence is propelling the gastroparesis market.

How Is The Gastroparesis Market Structured Across Different Segments?

The gastroparesis market covered in this report is segmented –

1) By Treatment Modality: Medications, Dietary Modifications, Medical Devices, Other Therapies

2) By Gastroparesis Type: Idiopathic, Diabetic, Post- Surgical, Other Types

3) By Patient Demographics: Pediatric Gastroparesis, Adult Gastroparesis

4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Other Distribution Channels

5) By End User: Hospitals And Clinics, Ambulatory Surgical Centers, Home Care Settings

Subsegments:

1) By Medications: Prokinetic Agents, Antiemetic Medications, Pain Management Medications

2) By Dietary Modifications: Low-Fiber Diets, Small, Frequent Meals, Pureed Or Liquid Diets

3) By Medical Devices: Gastric Electrical Stimulation Devices, Enteral Feeding Tubes

4) By Other Therapies: Acupuncture, Behavioral Therapies, Nutritional Supplements

What Industry Trends Are Redefining The Gastroparesis Market?

Leading companies operating within the gastroparesis market are focused on developing new drugs to enhance their market profitability. Medications utilized in gastroparesis treatment serve various functions to alleviate symptoms associated with delayed stomach emptying. For example, in December 2023, Vanda Pharmaceuticals Inc., a US-based Biopharmaceutical Company, reported that the U.S. FDA accepted the New Drug Application for Tradipitant, indicating promising progress towards its potential approval for gastroparesis treatment. The FDA has established September 18, 2024, as the Prescription Drug User Fee Act (PDUFA) decision date for Tradipitant. If approved, Tradipitant would represent the first FDA-approved novel drug for gastroparesis in over 40 years, signifying a major milestone as the first drug in more than three decades to undergo specific FDA review for this condition.

Which Major Players Dominate The Gastroparesis Market?

Major companies operating in the gastroparesis market are Pfizer Inc., GlaxoSmithKline plc., Abbott Laboratories Inc., AstraZeneca Plc., Medtronic Plc., Takeda Pharmaceutical Company Limited, Johnson And Johnson Services Inc., Teva Pharmaceutical Industries Ltd, AbbVie Inc., Boston Scientific Corporation, Cadila Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. ltd, ANI Pharmaceuticals Inc., Dompe Farmaceutici S.p.A, Sucampo Pharmaceuticals Inc., Ironwood Pharmaceuticals Inc., RedHill Biopharma Ltd., CinRx Pharma LLC, Ritter Pharmaceuticals Inc., Evoke Pharma Inc., Metacrine Inc., Neurogastrx Inc.

Read the full gastroparesis market report here:

https://www.thebusinessresearchcompany.com/report/gastroparesis-global-market-report

Which Region Currently Holds The Largest Share Of The Gastroparesis Market?

North America was the largest region in the gastroparesis market in 2025. The regions covered in the gastroparesis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Gastroparesis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12189&type=smp

Browse Through More Reports Similar to the Global Gastroparesis Market 2026, By The Business Research Company

Gastric Cancer Diagnostic Procedure Global Market Report

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-procedure-global-market-report

Germ Cell Tumor Global Market Report

https://www.thebusinessresearchcompany.com/report/germ-cell-tumor-global-market-report

Gastrointestinal Endoscopy Global Market Report

https://www.thebusinessresearchcompany.com/report/gastrointestinal-endoscopy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795